Print

Amexdrug Corp. (AXRX) Unveils New Product Line  
3/21/2007 1:11:43 PM

BEVERLY HILLS, CA -- (MARKET WIRE) -- March 21, 2007 -- Amexdrug Corporation (OTCBB: AXRX) today announced that it has completed formulation and market analysis, and has moved on to the initial production phase of its new line of five over-the-counter products aimed at fungal infections, brittle nails, as well as a topical analgesic. These over-the-counter natural products will be manufactured using all FDA-approved ingredients through Amexdrug's subsidiary Dermagen, Inc., and will be sold and marketed through another Amexdrug subsidiary, BioRX Pharmaceuticals.
//-->